Skip to content
by Legal Desire
SIGN IN GO PRO
Jurisdiction

Greater China

7 announced deals involving Greater China, most recent first, with the firms that advised on each.

Most recent

SEARCH ALL 7
Baker McKenzie Advises Takeda in Global Strategic Collaboration with Innovent Biologics 23 Oct 2025
Venture Capital & Growth Healthcare & Life Sciences Baker McKenzie USD 1.20bn 8 NAMED
Baker McKenzie Advises Takeda in Global Strategic Partnership with Innovent Biologics 23 Oct 2025
Joint Venture Healthcare & Life Sciences Baker McKenzie USD 1.20bn 8 NAMED
Clifford Chance advises Sanofi on acquisition of exclusive Greater China rights to develop and commercialise aficamten 20 Jan 2025
M&A Healthcare & Life Sciences Clifford Chance 4 NAMED
Kirkland Advises GLP Capital Partners on Sale of GCP International to Ares 10 Oct 2024
M&A Financial Services Kirkland & Ellis USD 3.70bn
Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences 14 Aug 2024
M&A Healthcare & Life Sciences Clifford Chance 16 NAMED
Sidley Represents Baozun in the Acquisition of Gap Greater China and its Voluntary Conversion to a Dual-Primary Listing on the Hong Kong Stock Exchange 14 Nov 2022
M&A Consumer & Retail Sidley 11 NAMED
Linklaters advises the PRC government on its €4bn bond offering 20 Nov 2020
Capital Markets & IPO Financial Services Linklaters EUR 4bn 3 NAMED